Healthcare Management I-Mab Receives IND Approval For Phase 1 Clinical Trial Of Bispecific Antibody TJ-CD4B in Solid… AIT News Desk Dec 15, 2021 I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced that…
Neuroscience I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge… AIT News Desk Jul 12, 2021 I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the…